Cholic acid
Bile Acid — ALIMENTARY TRACT AND METABOLISM
Also known as: cholalic acid, cholalin, cholbam, colalin, kolbam, orphacol
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Cholic acid is an ofp drug in the Bile Acid class catalogued in DrugCentral. It was first approved by the EMA in 2013. DrugCentral lists 2 molecular targets, including GPBAR1 and NR1H4. Recorded indications include 3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency, Calculus in biliary tract, Cholestanol storage disease and Constipation.
- Approval status: ofp (first approved 2013 by the EMA).
- Drug class: Bile Acid.
- Molecular targets: GPBAR1 and NR1H4 (2 listed in DrugCentral).
- Indications: 3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency, Calculus in biliary tract, Cholestanol storage disease, Constipation and Delta-4-3-oxosteroid-5-beta-reductase deficiency and others.
- ATC code: A05AA03 (Bile acids and derivatives).
- Molecular formula: C24H40O5; molecular weight 408.58 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (8)
- 3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency
- Calculus in biliary tract
- Cholestanol storage disease
- Constipation
- Delta-4-3-oxosteroid-5-beta-reductase deficiency
- Disorder of biliary tract
- Inborn error of bile acid metabolism
- Incomplete passage of stool
Contraindications (12)
- Appendicitis
- Diarrhea
- Disease of liver
- Gallstone Complications
- Gastrointestinal obstruction
- Hypercholesterolemia
- Incontinence of feces
- Liver function tests abnormal
- Obstruction of bile duct
- Pregnancy, function
- Primary biliary cirrhosis
- Sclerosing cholangitis
Mechanism & targets
| Established pharmacologic class | Bile Acid |
|---|
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| G-protein coupled bile acid receptor 1 | GPBAR1 | agonist | EC50 5.00 |
| Bile acid receptor | NR1H4 | unknown | EC50 4.35 |
Regulatory approvals (3)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2023-03-27 | PMDA | — | ReqMed Company, Ltd | Yes |
| 2015-03-17 | FDA | — | RTRX | Yes |
| 2013-09-12 | EMA | — | Laboratoires CTRS | Yes |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
A05AA03 | ALIMENTARY TRACT AND METABOLISM › BILE AND LIVER THERAPY › BILE THERAPY › Bile acids and derivatives |
Pharmacogenomics
Drug-label and guideline annotations from PharmGKB and CPIC.
- EMA label: AKR1D1, HSD3B7
- FDA label: AKR1D1, AMACR, CYP27A1, CYP7A1, DHCR7
Chemical structure
| Molecular formula | C24H40O5 |
|---|---|
| Molecular weight | 408.58 g/mol |
| CAS number | 81-25-4 |
| InChIKey | BHQCQFFYRZLCQQ-OELDTZBJSA-N |
| PubChem CID | 221493 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Cholic acid used for?
DrugCentral lists the following indications for Cholic acid: 3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency, Calculus in biliary tract, Cholestanol storage disease, Constipation, Delta-4-3-oxosteroid-5-beta-reductase deficiency, Disorder of biliary tract, Inborn error of bile acid metabolism and Incomplete passage of stool.
How does Cholic acid work?
Its molecular targets in DrugCentral include GPBAR1 (agonist) and NR1H4.
When was Cholic acid first approved?
Cholic acid was first approved by the EMA in 2013.
What drug class does Cholic acid belong to?
Cholic acid is in the Bile Acid class.
What is the chemical formula of Cholic acid?
Cholic acid has the molecular formula C24H40O5 and a molecular weight of 408.58 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3096 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL205596 — compound record and bioactivity
- PubChem CID 221493 — chemical identifiers
- DrugBank DB02659 — drug record
- FDA UNII G1JO7801AE — substance identity
- DailyMed: FDA labels for Cholic acid — current prescribing information (label search)
- UniProt Q8TDU6 (GPBAR1) — target protein
- UniProt Q96RI1 (NR1H4) — target protein
- PharmGKB / CPIC — pharmacogenomic label annotations
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.